Cargando…

Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation

PURPOSE: MicroRNA-218 (miR-218) is a key regulator of numerous processes relevant to tumor progression. In the present study, we aimed to characterize the relationship between miR-218 and the Epidermal Growth Factor Receptor (EGFR) as well as to understand downstream effects in triple-negative breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Wischmann, Franz-Josef, Troschel, Fabian M., Frankenberg, Maj, Kemper, Björn, Vijaya Kumar, Archana, Sicking, Mark, Ibrahim, Sherif Abdelaziz, Kiesel, Ludwig, Götte, Martin, Eich, Hans Theodor, Greve, Burkhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374822/
https://www.ncbi.nlm.nih.gov/pubmed/37088795
http://dx.doi.org/10.1007/s00432-023-04750-x
_version_ 1785078860651429888
author Wischmann, Franz-Josef
Troschel, Fabian M.
Frankenberg, Maj
Kemper, Björn
Vijaya Kumar, Archana
Sicking, Mark
Ibrahim, Sherif Abdelaziz
Kiesel, Ludwig
Götte, Martin
Eich, Hans Theodor
Greve, Burkhard
author_facet Wischmann, Franz-Josef
Troschel, Fabian M.
Frankenberg, Maj
Kemper, Björn
Vijaya Kumar, Archana
Sicking, Mark
Ibrahim, Sherif Abdelaziz
Kiesel, Ludwig
Götte, Martin
Eich, Hans Theodor
Greve, Burkhard
author_sort Wischmann, Franz-Josef
collection PubMed
description PURPOSE: MicroRNA-218 (miR-218) is a key regulator of numerous processes relevant to tumor progression. In the present study, we aimed to characterize the relationship between miR-218 and the Epidermal Growth Factor Receptor (EGFR) as well as to understand downstream effects in triple-negative breast cancer (TNBC). METHODS: We assessed miR-218 and EGFR expression in cell lines and publicly available primary breast cancer gene expression data. We then overexpressed miR-218 in two TNBC cell lines and investigated effects on EGFR and downstream mitogen-activated protein (MAP) kinase signaling. Luciferase reporter assay was used to characterize a direct binding interaction between miR-218 and EGFR mRNA. Digital holographic microscopy helped investigate cell migration and dry mass after miR-218 overexpression. Cell division and invasion were assessed microscopically, while radiation response after miR-218 overexpression alone or combined with additional EGFR knockdown was investigated via clonogenic assays. RESULTS: We found an inverse correlation between EGFR expression and miR-218 levels in cell lines and primary breast cancer tissues. MiR-218 overexpression resulted in a downregulation of EGFR via direct binding of the mRNA. Activation of EGFR and downstream p44/42 MAPK signaling were reduced after pre-miR-218 transfection. Cell proliferation, motility and invasiveness were inhibited whereas cell death and mitotic catastrophe were upregulated in miR-218 overexpressing cells compared to controls. MiR-218 overexpressing and EGFR siRNA-treated cells were sensitized to irradiation, more than miR-218 overexpressing cells alone. CONCLUSION: This study characterizes the antagonistic relationship between miR-218 and EGFR. It also demonstrates downstream functional effects of miR-218 overexpression, leading to anti-tumorigenic cellular changes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04750-x.
format Online
Article
Text
id pubmed-10374822
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-103748222023-07-29 Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation Wischmann, Franz-Josef Troschel, Fabian M. Frankenberg, Maj Kemper, Björn Vijaya Kumar, Archana Sicking, Mark Ibrahim, Sherif Abdelaziz Kiesel, Ludwig Götte, Martin Eich, Hans Theodor Greve, Burkhard J Cancer Res Clin Oncol Research PURPOSE: MicroRNA-218 (miR-218) is a key regulator of numerous processes relevant to tumor progression. In the present study, we aimed to characterize the relationship between miR-218 and the Epidermal Growth Factor Receptor (EGFR) as well as to understand downstream effects in triple-negative breast cancer (TNBC). METHODS: We assessed miR-218 and EGFR expression in cell lines and publicly available primary breast cancer gene expression data. We then overexpressed miR-218 in two TNBC cell lines and investigated effects on EGFR and downstream mitogen-activated protein (MAP) kinase signaling. Luciferase reporter assay was used to characterize a direct binding interaction between miR-218 and EGFR mRNA. Digital holographic microscopy helped investigate cell migration and dry mass after miR-218 overexpression. Cell division and invasion were assessed microscopically, while radiation response after miR-218 overexpression alone or combined with additional EGFR knockdown was investigated via clonogenic assays. RESULTS: We found an inverse correlation between EGFR expression and miR-218 levels in cell lines and primary breast cancer tissues. MiR-218 overexpression resulted in a downregulation of EGFR via direct binding of the mRNA. Activation of EGFR and downstream p44/42 MAPK signaling were reduced after pre-miR-218 transfection. Cell proliferation, motility and invasiveness were inhibited whereas cell death and mitotic catastrophe were upregulated in miR-218 overexpressing cells compared to controls. MiR-218 overexpressing and EGFR siRNA-treated cells were sensitized to irradiation, more than miR-218 overexpressing cells alone. CONCLUSION: This study characterizes the antagonistic relationship between miR-218 and EGFR. It also demonstrates downstream functional effects of miR-218 overexpression, leading to anti-tumorigenic cellular changes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04750-x. Springer Berlin Heidelberg 2023-04-23 2023 /pmc/articles/PMC10374822/ /pubmed/37088795 http://dx.doi.org/10.1007/s00432-023-04750-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Wischmann, Franz-Josef
Troschel, Fabian M.
Frankenberg, Maj
Kemper, Björn
Vijaya Kumar, Archana
Sicking, Mark
Ibrahim, Sherif Abdelaziz
Kiesel, Ludwig
Götte, Martin
Eich, Hans Theodor
Greve, Burkhard
Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation
title Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation
title_full Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation
title_fullStr Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation
title_full_unstemmed Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation
title_short Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation
title_sort tumor suppressor mir-218 directly targets epidermal growth factor receptor (egfr) expression in triple-negative breast cancer, sensitizing cells to irradiation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374822/
https://www.ncbi.nlm.nih.gov/pubmed/37088795
http://dx.doi.org/10.1007/s00432-023-04750-x
work_keys_str_mv AT wischmannfranzjosef tumorsuppressormir218directlytargetsepidermalgrowthfactorreceptoregfrexpressionintriplenegativebreastcancersensitizingcellstoirradiation
AT troschelfabianm tumorsuppressormir218directlytargetsepidermalgrowthfactorreceptoregfrexpressionintriplenegativebreastcancersensitizingcellstoirradiation
AT frankenbergmaj tumorsuppressormir218directlytargetsepidermalgrowthfactorreceptoregfrexpressionintriplenegativebreastcancersensitizingcellstoirradiation
AT kemperbjorn tumorsuppressormir218directlytargetsepidermalgrowthfactorreceptoregfrexpressionintriplenegativebreastcancersensitizingcellstoirradiation
AT vijayakumararchana tumorsuppressormir218directlytargetsepidermalgrowthfactorreceptoregfrexpressionintriplenegativebreastcancersensitizingcellstoirradiation
AT sickingmark tumorsuppressormir218directlytargetsepidermalgrowthfactorreceptoregfrexpressionintriplenegativebreastcancersensitizingcellstoirradiation
AT ibrahimsherifabdelaziz tumorsuppressormir218directlytargetsepidermalgrowthfactorreceptoregfrexpressionintriplenegativebreastcancersensitizingcellstoirradiation
AT kieselludwig tumorsuppressormir218directlytargetsepidermalgrowthfactorreceptoregfrexpressionintriplenegativebreastcancersensitizingcellstoirradiation
AT gottemartin tumorsuppressormir218directlytargetsepidermalgrowthfactorreceptoregfrexpressionintriplenegativebreastcancersensitizingcellstoirradiation
AT eichhanstheodor tumorsuppressormir218directlytargetsepidermalgrowthfactorreceptoregfrexpressionintriplenegativebreastcancersensitizingcellstoirradiation
AT greveburkhard tumorsuppressormir218directlytargetsepidermalgrowthfactorreceptoregfrexpressionintriplenegativebreastcancersensitizingcellstoirradiation